Hi, what are you looking for?
The first head-to-head clinical trial pushes the psychedelic compound closer to becoming a licensed medicine
A first-of-its-kind clinical trial shows a dramatic drop in depression in over half of patients who received a synthetic version of the compound
Extracting psilocybin from magic mushrooms will be cheaper than current method of creating synthetic compound for research, says company
Research, therapeutic and medical drug development and investment can all flourish under pre-existing legal pathways, experts say